Skip to main content

OncoMethylome/LabCorp’s MGMT Test

Laboratory Corporation of America this week commercially launched its MGMT methylation testing service to gauge patients’ responsiveness to cancer therapies. 
For the test, LabCorp licensed OncoMethylome's MSP and MGMT DNA methylation marker technology.
OncoMethylome Sciences will receive royalty and milestone payments from LabCorp on the sales of the MGMT methylation testing service. Financial terms of the deal were not announced.
While its deal with LabCorp is for the North American market, OncoMethylome noted that efforts are underway to extend commercial availability of its technology to the European markets.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.